Monday, August 14, 2023

The Lord Giveth, Taketh Away: CMS Rescinds Coverage for LDT PSA Test under NCD for PSA Screening

Back on June 15, 2023, I published the surprising announcement that CMS was covering an LDT PSA-related test under the NCD for prostate screening.   This would be unusual, because of CMS's preference (both stated, and observed) for only handling FDA-authorized tests under NCDs.

The wheels turn.   On August 3, 2023, CMS issued a transmittal - CR 13278 - which retracts coverage for test. Test 0359U is no longer covered under the NCD as a national prostate screening test.